| Name | Title | Contact Details |
|---|---|---|
Nathan Ross |
Director of Sales | Profile |
Nathaniel Lee |
Director of Growth Management | Profile |
Simon Curtis |
Vice President, Revenue, Biz Dev and | Profile |
Sandy Micone |
Vice President, Brand & Product Design | Profile |
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Austin WebCo is a Austin, TX-based company in the Software & Internet sector.
Dolphmap Co is a Fort Lauderdale, FL-based company in the Software and Internet sector.
Ascent Solutions is a company that provides native Salesforce apps for ERP, inventory, rentals, labels, and omnichannel orders that provide Operations 360 on the platform.
Omatic Software is the award-winning company offering nonprofit data integration tools to all types of charitable organizations. We help advance fundraising efforts, database management, and data collection for nonprofit organizations.